Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E M Schaeffer

Showing results (11-20 of 22) with videos related to

Pageof 3
Sort By:
International Journal of Impotence Research|October 14, 2011
Increased expression of nestin in the major pelvic ganglion following cavernous nerve injuryO Kutlu, A E Ross, E M Schaeffer, et al.
Medical Oncology (Northwood, London, England)|June 12, 2020
Multidisciplinary total eradication therapy (TET) in men with newly diagnosed oligometastatic prostate cancerD K Reyes, S P Rowe, E M Schaeffer, et al.
Science (New York, N.Y.)|April 24, 1999
Requirement for Tec kinases Rlk and Itk in T cell receptor signaling and immunityE M Schaeffer, J Debnath, G Yap, et al.
Nature|April 4, 2000
PKC-theta is required for TCR-induced NF-kappaB activation in mature but not immature T lymphocytesZ Sun, C W Arendt, W Ellmeier, et al.
Prostate Cancer and Prostatic Diseases|November 6, 2013
Very-high-risk localized prostate cancer: definition and outcomesD Sundi, V M Wang, P M Pierorazio, et al.
Prostate Cancer and Prostatic Diseases|January 25, 2017
Use of the Prostate Health Index for detection of prostate cancer: results from a large academic practiceJ J Tosoian, S C Druskin, D Andreas, et al.
Prostate Cancer and Prostatic Diseases|October 23, 2013
A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomyA E Ross, F Y Feng, M Ghadessi, et al.
Prostate Cancer and Prostatic Diseases|May 20, 2015
High-throughput transcriptomic analysis nominates proteasomal genes as age-specific biomarkers and therapeutic targets in prostate cancerS G Zhao, W C Jackson, V Kothari, et al.
BMJ Open|May 19, 2023
Protocol of a multicentre randomised controlled trial assessing transperineal prostate biopsy to reduce infectiouscomplicationsJim Hu, Alec Zhu, Andrew Vickers, et al.
Prostate Cancer and Prostatic Diseases|November 2, 2016
Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysisB Benzon, S G Zhao, M C Haffner, et al.
Pageof 3

Showing results (11-20 of 22) with videos related to

Sort By:
Pageof 3
International Journal of Impotence Research|October 14, 2011
Increased expression of nestin in the major pelvic ganglion following cavernous nerve injuryO Kutlu, A E Ross, E M Schaeffer, et al.
Medical Oncology (Northwood, London, England)|June 12, 2020
Multidisciplinary total eradication therapy (TET) in men with newly diagnosed oligometastatic prostate cancerD K Reyes, S P Rowe, E M Schaeffer, et al.
Science (New York, N.Y.)|April 24, 1999
Requirement for Tec kinases Rlk and Itk in T cell receptor signaling and immunityE M Schaeffer, J Debnath, G Yap, et al.
Nature|April 4, 2000
PKC-theta is required for TCR-induced NF-kappaB activation in mature but not immature T lymphocytesZ Sun, C W Arendt, W Ellmeier, et al.
Prostate Cancer and Prostatic Diseases|November 6, 2013
Very-high-risk localized prostate cancer: definition and outcomesD Sundi, V M Wang, P M Pierorazio, et al.
Prostate Cancer and Prostatic Diseases|January 25, 2017
Use of the Prostate Health Index for detection of prostate cancer: results from a large academic practiceJ J Tosoian, S C Druskin, D Andreas, et al.
Prostate Cancer and Prostatic Diseases|October 23, 2013
A genomic classifier predicting metastatic disease progression in men with biochemical recurrence after prostatectomyA E Ross, F Y Feng, M Ghadessi, et al.
Prostate Cancer and Prostatic Diseases|May 20, 2015
High-throughput transcriptomic analysis nominates proteasomal genes as age-specific biomarkers and therapeutic targets in prostate cancerS G Zhao, W C Jackson, V Kothari, et al.
BMJ Open|May 19, 2023
Protocol of a multicentre randomised controlled trial assessing transperineal prostate biopsy to reduce infectiouscomplicationsJim Hu, Alec Zhu, Andrew Vickers, et al.
Prostate Cancer and Prostatic Diseases|November 2, 2016
Correlation of B7-H3 with androgen receptor, immune pathways and poor outcome in prostate cancer: an expression-based analysisB Benzon, S G Zhao, M C Haffner, et al.
Pageof 3